Literature DB >> 12100092

Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness.

E P Calandre1, J Bembibre, M L Arnedo, D Becerra.   

Abstract

The purpose of the present study was to evaluate neuropsychological performance and regional cerebral blood flow in migraine patients, and to investigate whether possible abnormalities in any of these fields could be related to the chronicity of the disease. The sample included 60 patients and 30 healthy control subjects; all of them were subjected to a complete neuropsychological assessment, including emotional variables. In addition an interictal 99Tc-HMPAO SPECT was performed in 56 patients and 15 controls. Disturbances in memory, attention and visuomotor speed processing were observed among migraineurs experiencing higher frequency of attacks and in those with a long history of migraine. Anxiety levels were higher in patients than in controls and were positively correlated with attack frequency, but not with cognitive test scores. Brain perfusion abnormalities, mostly hypoperfusion areas, were found in the 43% of patients; poorer performance in two tests, measuring verbal and visual memory, respectively, was found in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100092     DOI: 10.1046/j.1468-2982.2002.00370.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  57 in total

Review 1.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

2.  Fugue associated with migraine.

Authors:  G Porter; T Shaw; C J Ryan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

3.  Migraine and cognitive decline in the population-based EVA study.

Authors:  Pamela M Rist; Carole Dufouil; M Maria Glymour; Christophe Tzourio; Tobias Kurth
Journal:  Cephalalgia       Date:  2011-08-04       Impact factor: 6.292

4.  Migraine mutations impair hippocampal learning despite enhanced long-term potentiation.

Authors:  Ergin Dilekoz; Thijs Houben; Katharina Eikermann-Haerter; Mustafa Balkaya; A Mariette Lenselink; Michael J Whalen; Sabine Spijker; Michel D Ferrari; Arn M J M van den Maagdenberg; Cenk Ayata
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

Review 5.  Neuropsychiatric Disorders as Erratic Attention Regulation - Lessons from Electrophysiology.

Authors:  Goded Shahaf
Journal:  Psychiatr Q       Date:  2019-12

6.  Decreased activation of cingulo-frontal-parietal cognitive/attention network during an attention-demanding task in patients with chronic low back pain.

Authors:  Cui Ping Mao; Qiu Li Zhang; Fa Xiu Bao; Xia Liao; Xiao Li Yang; Ming Zhang
Journal:  Neuroradiology       Date:  2014-07-02       Impact factor: 2.804

7.  Magnitude and variability of effect sizes for the associations between chronic pain and cognitive test performances: a meta-analysis.

Authors:  Michél Rathbone; William Parkinson; Yasir Rehman; Shucui Jiang; Mohit Bhandari; Dinesh Kumbhare
Journal:  Br J Pain       Date:  2016-07-19

Review 8.  ADHD is associated with migraine: a systematic review and meta-analysis.

Authors:  Haitham Salem; David Vivas; Fei Cao; Iram F Kazimi; Antonio L Teixeira; Cristian P Zeni
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-09-13       Impact factor: 4.785

9.  Benign epilepsy of childhood with centro-temporal spikes (BECTS) versus migraine: a neuropsychological assessment.

Authors:  Pasquale Parisi; Sara Matricardi; Elisabetta Tozzi; Enzo Sechi; Claudia Martini; Alberto Verrotti
Journal:  Childs Nerv Syst       Date:  2012-09-08       Impact factor: 1.475

10.  Headache and cognitive profile in children: a cross-sectional controlled study.

Authors:  Pasquale Parisi; Alberto Verrotti; Maria Chiara Paolino; Antonella Urbano; Mariangela Bernabucci; Rosa Castaldo; Maria Pia Villa
Journal:  J Headache Pain       Date:  2009-10-20       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.